Taking advantage of a previously published RNA-seq dataset evaluating the splicing outcome of PRMT5 inhibition in a patient-derived glioblastoma cell culture system [52], we carried out splicing event overlap analyses with our RNA-seq datasets (‘PRMT5 inhibition’ and ‘MDA-MB468-M-H+’ analysis). The gene discussed is PRMT5; the disease is glioblastoma.